However, in colon cancer, hypermethylation of the CpG island of the TBX5 promoter results in the inability of the promoter region to bind transcription-associated proteins, inhibiting TBX5 transcriptional activity leads to the development of malignant tumors [57]. Here, TBX5 is linked to malignant colon neoplasm.